Search results
Results From The WOW.Com Content Network
Royalty Pharma (RPRX) delivered earnings and revenue surprises of 1.43% and 0.10%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Repros Therapeutics Inc. ( Nasdaq : RPRX), was a US -based development stage biopharmaceutical company headquartered in The Woodlands, Texas. Founded in 1987 as Zonagen, it focused on the development of oral small molecule drugs to address major unmet medical needs in male and female health. Joseph S. Podolski [1] was the CEO of this company.
EVP & CFO of Royalty Pharma Plc (30-Year Financial, Insider Trades) Terrance P. Coyne (insider trades) sold 100,000 shares of RPRX on 03/03/2021 at an average price of $44.78 a share.
S&P 500 Dividend Aristocrats. The S&P 500 Dividend Aristocrats is a stock market index composed of the companies in the S&P 500 index that have increased their dividends in each of the past 25 consecutive years. It was launched in May 2005.
A dividend is a distribution of profits by a corporation to its shareholders. When a corporation earns a profit or surplus, it is able to pay a portion of the profit as a dividend to shareholders. Any amount not distributed is taken to be re-invested in the business (called retained earnings ).
Dividend stocks are proven wealth creators. Over the last 50 years, they have outperformed non-payers by more than 2 to 1. A big driver is their steady (and often growing) income stream, which ...
Earnings per share ( EPS) is the monetary value of earnings per outstanding share of common stock for a company. It is a key measure of corporate profitability and is commonly used to price stocks. [1] In the United States, the Financial Accounting Standards Board (FASB) requires EPS information for the four major categories of the income ...
Dividend yield. The dividend yield or dividend–price ratio of a share is the dividend per share divided by the price per share. [1] It is also a company's total annual dividend payments divided by its market capitalization, assuming the number of shares is constant. It is often expressed as a percentage.